Kidswell Bio Corp. engages in the pharmaceutical development business. The firm’s business contents include the biosimilars, new biopharmaceutical, and cell therapy businesses. The company was founded on March 1, 2001 and is headquartered in Tokyo, Japan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company